Early identification of women with HELLP syndrome who need plasma exchange after delivery

Transfusion and Apheresis Science

Volumn 52, Issue 1, 2015, Pages 54-59

  Simetka, O ^a,b   Klat, J ^a   Gumulec, J ^a   Dolezalkova, E ^a   Salounova, D ^c   Kacerovsky, M ^d  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

^c VSB TECHNICAL UNIVERSITY OF OSTRAVA   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

HELLP syndrome; Maternal morbidity; Plasmapheresis; Postpartum plasma exchange; Postpartum thrombotic microangiopathic syndrome

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BETAMETHASONE; BILIRUBIN; CREATININE; DEXAMETHASONE; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; UREA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DELIVERY; DISEASE COURSE; FEMALE; HELLP SYNDROME; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; PLASMAPHERESIS; POSTPARTUM THROMBOTIC MICROANGIOPATHIC SYNDROME; RETROSPECTIVE STUDY; THROMBOCYTE; UREA BLOOD LEVEL; BLOOD; CLINICAL TRIAL; LIVE BIRTH; PREGNANCY; PUERPERAL DISORDERS; PUERPERIUM; THROMBOTIC MICROANGIOPATHIES; TIME;

ADULT; FEMALE; HELLP SYNDROME; HUMANS; LIVE BIRTH; PLASMA EXCHANGE; POSTPARTUM PERIOD; PREGNANCY; PUERPERAL DISORDERS; THROMBOTIC MICROANGIOPATHIES; TIME FACTORS;

EID: 84926228483     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.12.009     Document Type: Article

References (22)

1. Owens M.Y., Martin J.N., Wallace K., Keiser S.D., Parrish M.R., Tam K.B.T., et al. Postpartum thrombotic microangiopathic syndrome. Transfus Apher Sci 2013, 48:51-57.
2. Martin J.N. Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). Int J Gynaecol Obstet 2013, 121:202-207.
3. Del Fante C., Perotti C., Viarengo G., Gallini G.S., Tinelli C., Salvaneschi L. Daily plasma-exchange for life-threatening class I HELLP syndrome with prevalent pulmonary involvement. Transfus Apher Sci 2006, 34:7-9.
4. Forster J.G., Peltonen S., Kaaja R., Lampinen K., Pettila V. Plasma exchange in severe postpartum HELLP syndrome. Acta Anaesthesiol Scand 2002, 46:955-958.
5. Simetka O. [HELLP syndrome - diagnostics and management. Clinical guideline]. Ceska Gynekol 2014, 79:4.
6. Martin J.N., Owens M.Y., Keiser S.D., Parrish M.R., Tam K.B.T., Brewer J.M., et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy 2012, 31:79-90.
7. Isler C.M., Rinehart B.K., Terrone D.A., Martin R.W., Magann E.F., Martin J.N. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999, 181:924-928.
8. Eser B., Guven M., Unal A., Coskun R., Altuntas F., Sungur M., et al. The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost 2005, 11:211-217.
9. Hamada S., Takishita Z., Tamura T., Naka O., Higuchi K., Takahashi H. Plasma exchange in a patient with postpartum HELLP syndrome. J Obstet Gynaecol Res 1996, 22:371-374.
10. Martin J.N., Files J.C., Blake P.G., Perry K.G., Morrison J.C., Norman P.H. Postpartum plasma-exchange for atypical preeclampsia-eclampsia as HELLP (Hemolysis, Elevated Liver-Enzymes, and Low Platelets) syndrome. Am J Obstet Gynecol 1995, 172:1107-1127.
11. Lampinen K., Peltonen S., Pettila V., Kaaja R. Treatment of postpartum thrombotic microangiopathy with plasma exchange using cryosupernatant as replacement. Acta Obstet Gynecol Scand 2004, 83:175-179.
12. Simetka O., Michalec I., Zewdiova H., Kolarova R., Prochazkova J., Prochazka M. [Course and delivery outcomes of 34 pregnancies complicated by HELLP syndrom]. Ceska Gynekol 2010, 75:242-247.
13. Julius C.J., Dunn Z.L., Blazina J.F. HELLP syndrome: laboratory parameters and clinical course in four patients treated with plasma exchange. J Clin Apher 1994, 9:228-235.
14. Mokrzycki M.H., Balogun R.A. Therapeutic apheresis: a review of complications and recommendations for prevention and management. J Clin Apher 2011, 26:243-248.
15. Norda R., Berseus O., Stegmayr B. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry. Transfus Apher Sci 2001, 25:33-41.
16. Shemin D., Briggs D., Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher 2007, 22:270-276.
17. Spencer C.D., Crane F.M., Kumar J.R., Alving B.M. Treatment of postpartum hemolytic uremic syndrome with plasma exchange. JAMA 1982, 247:2808-2809.
18. Shrivastava M., Modi G., Singh R.K., Navaid S. Early diagnosis and management of postpartum hemolytic uremic syndrome with plasma exchange. Transfus Apher Sci 2011, 44:257-262.
19. Shemin D., Dworkin L.D. Clinical outcome in three patients with postpartum hemolytic uremic syndrome treated with frequent plasma exchange. Ther Apher 1998, 2:43-48.
20. Myers L. Postpartum plasma exchange in a woman with suspected thrombotic thrombocytopenic purpura (TTP) vs. hemolysis, elevated liver enzymes, and low platelet syndrome (HELLP): a case study. Nephrol Nurs J 2010, 37:399-402.
21. Martin J.N., Briery C.M., Rose C.H., Owens M.T., Bofill J.A., Files J.C. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy. J Clin Apher 2008, 23:138-143.
22. Slavik L., Prochazkova J., Prochazka M., Simetka O., Hlusi A., Ulehlova J. The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011, 155:333-337.